Fifteen-Year Population Attributable Fractions and Causal Pies of Risk Factors for Newly Developed Hepatocellular Carcinomas in 11,801 Men in Taiwan by Liao, Shu-Fen et al.
Fifteen-Year Population Attributable Fractions and
Causal Pies of Risk Factors for Newly Developed
Hepatocellular Carcinomas in 11,801 Men in Taiwan
Shu-Fen Liao
1, Hwai-I Yang
2, Mei-Hsuan Lee
3, Chien-Jen Chen
3, Wen-Chung Lee
1*
1Research Center for Genes, Environment and Human Health, and Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan
University, Taipei, Taiwan, 2Molecular and Genomic Epidemiology Center, China Medical University Hospital and Graduate Institute of Clinical Medical Science, China
Medical University, Taichung, Taiwan, 3Genomics Research Center, Academia Sinica, Taipei, Taiwan
Abstract
Development of hepatocellular carcinoma (HCC) is a multi-factorial process. Chronic infections with hepatitis B virus (HBV)
and hepatitis C virus (HCV) are important risk factors of HCC. Host factors, such as alcohol drinking, may also play a role. This
study aims to provide a synthesis view on the development of HCC by examining multiple risk factors jointly and
collectively. Causal-pie modeling technique was applied to analyze a cohort of 11,801 male residents (followed up for 15
years) in Taiwan, during which a total of 298 incident HCC cases were ascertained. The rate ratios adjusted by age were
further modeled by an additive Poisson regression. Population attributable fractions (PAFs) and causal-pie weights (CPWs)
were calculated. A PAF indicates the magnitude of case-load reduction under a particular intervention scenario, whereas a
CPW for a particular class of causal pies represents the proportion of HCC cases attributable to that class. Using PAF we
observed a chance to reduce around 60% HCC risk moving from no HBV-related intervention to the total elimination of the
virus. An additional ,15% (or ,5%) reduction can be expected, if the HBV-related intervention is coupled with an HCV-
related intervention (or an anti-drinking campaign). Eight classes of causal pies were found to be significant, including four
dose-response classes of HBV (total CPW=52.7%), one independent-effect class of HCV (CPW=14.4%), one HBV-alcohol
interaction class (CPW=4.2%), one HBV-HCV interaction class (CPW=1.7%), and one all-unknown class (CPW=27.0%).
Causal-pie modeling for HCC helps clarify the relative importance of each viral and host factor, as well as their interactions.
Citation: Liao S-F, Yang H-I, Lee M-H, Chen C-J, Lee W-C (2012) Fifteen-Year Population Attributable Fractions and Causal Pies of Risk Factors for Newly
Developed Hepatocellular Carcinomas in 11,801 Men in Taiwan. PLoS ONE 7(4): e34779. doi:10.1371/journal.pone.0034779
Editor: Julian Little, University of Ottawa, Canada
Received May 23, 2011; Accepted March 9, 2012; Published April 10, 2012
Copyright:  2012 Liao et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was partly supported by a grant from the National Science Council, Taiwan (NSC99-2628-B-002-061-MY3). The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript. These authors have no additional external support or funding to report.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: wenchung@ntu.edu.tw
Introduction
Hepatocellular carcinoma (HCC) is one of the most common
cancers in the world [1]. It represents 7.9% in men and 6.5% in
women, of the total new cancer cases reported each year [1].
Worldwide, the incidence rate is 10.8 per 100,000 person years
(16.0 for males and 6.0 for females) [1]. Taiwan is considered a
high incidence country, and the incidence rates reported from
national cancer registry in 2007 are 52.8 and 20.5 per 100,000
person years in men and in women, respectively [2].
Chronic infection with hepatitis B virus (HBV) has been
recognized as a major cause of HCC [3–8]. More than 350 million
persons live with HBV infection worldwide [9,10]. Previous
epidemiologic studies showed that the risk of HCC associated with
HBV infection ranges from 5-fold to 98-fold with a population
attributable fraction (PAF) of 8% to 94% [3]. A significant dose-
response relationship was also observed between HBV DNA level
(which quantifies viral replication in human body) and HCC risk
[9,11,12]. Hepatitis C virus (HCV), with 170 million persons all
over the world infected with it, is another important cause of HCC
[3,5,8,13,14]. Results from a meta-analysis show that there is a
remarkable geographic variation for the association between HCV
and HCC risk, with the odds ratio ranging from 11.5 in countries
at high HBV endemicity such as Taiwan and sub-Saharan Africa
to 31.2 in countries predominant for HCV infection such as Japan
[15]. A dose-response relationship can also be demonstrated
between HCV RNA level and HCC risk [13].
Although the independent effects of the above HBV and HCV
infections had been well characterized, their possible ‘interactions’
are less known (whether co-infection of HBV and HCV increases
or decreases the predicted HCC risk calculated from a simple
multiplication or addition of the two risks corresponding to each
individual virus, and by how much?) [3,14,16–18]. Also,
development of HCC is a multi-factorial process [3,19]. Besides
viral factors, ‘host’ factors (such as alcohol drinking and cigarette
smoking) may also play certain roles [3]. They may also exhibit
some sorts of interactions, including the host-host type or the host-
virus type [20–22]. In this study, we apply a newly developed
causal-pie modeling technique [23] to analyze a cohort conducted
in Taiwan—the community-based cancer screening program
(CBCSP) [16]. We aim to provide a synthesis view on the
development of HCC by examining multiple risk factors jointly
and collectively. We also quantify the relative importance of each
viral and host factor, and their interactions.
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Recruitment and Follow-up of Subjects
The CBCSP cohort started in 1991 to 1992 [16]. A total of
89,293 individuals aged 30 to 65 years residing in seven townships
(Sanchi, Chutung, Potzu, Kaoshu, Makung, Paihsa, and Huhsi) in
Taiwan were invited. A total of 23,820 individuals agreed to
participate and provided the written informed consents for
interview, health examination and blood collection. Demographic
data for residents who did not participate in the study were quite
similar to those of residents who agreed to participate except in
educational level [24]. Standardized personal interviews were
conducted to obtain baseline information on socio-demographic
characteristics, cigarette smoking, alcohol drinking, etc. At study
entry, all participants received abdominal ultrasonography and
donated their blood for various serological tests including hepatitis
B surface antigen (HBsAg) and antibodies against hepatitis C virus
(anti-HCV). Further quantification of HBV DNA or HCV RNA
loads was done for those participants with seropositivity of HBsAg
or anti-HCV [9,13]. The CBCSP cohort participants were
followed up until December 31, 2006. During the follow-up
period, a total of 437 newly developed HCC cases (298 for men
and 139 for women) were ascertained through the computerized
data linkage with national cancer registry in Taiwan. The
ascertainment was ensured to be complete and accurate by the
verification with the profiles on the national death certification
system.
Restriction on Male Subjects
In this study, we restricted our analysis on the male subset of the
cohort to specifically investigate causal pies of risk factors for HCC
in men. (Pathogenesis of HCC has been considered different
between men and women [3,25,26]. Sexual comparison of HCC
causal pies should be an interesting topic for further study.) The
distributions of township residence, age and education among
male responders and non-responders were presented in Table S1.
Overall, men who participated in the cohort are older, and with a
higher-proportion having low-level education, than those who did
not. Some differences in residential area distributions between
responders and non-responders were also noted.
A total of 11,801 men who were free of liver cirrhosis and HCC
at study entry were included for the present study. The study was
approved by the Institutional Review Board of the College of
Public Health, National Taiwan University (Taipei, Taiwan).
Causal-Pie Modeling
Liao and Lee’s causal-pie modeling technique [23] was applied
to analyze the data. It consists of the following four steps: 1)
adjusting for confounders (age in this study) using an ordinary
(multiplicative) model, 2) building an additive model with non-
negative parameters using a stepwise model selection algorithm, 3)
calculating population attributable fractions (PAFs) to present the
fraction of case subjects that would be prevented under various
public health intervention or treatment strategies, based on the
final model built in the previous step, and 4) solving a system of
PAF equations to obtain the causal-pie weights (CPWs; defined as
proportion of case subjects attributable to a particular class of
causal pies). It should be noted that the additive model in step 2
also uses the ratio-scale indices, such as an odds ratio (OR) or a
rate ratio (RR), to gauge exposure-disease relations. ‘Additive’
here indicates that the ORs or RRs themselves follow a ‘linear’
relation (instead of a ‘log-linear’ relation) and not that we are
resorting to difference-scale indices, such as a risk difference or a
rate difference.
In addition, we extend the method of Liao and Lee [23] in two
ways to encompass the scenarios in this study. First, the present
study is a cohort study with person-time data instead of a case-
control study with pure-count data considered in Liao and Lee’s
paper [23]. Therefore, we change the fundamental index from an
OR (for pure-count data) to an RR (for person-time data) and the
regression method from a ‘logistic regression’ (for pure-count data)
to a ‘Poisson regression’ (for person-time data). Second, Liao and
Lee [23] only considered risk factors that are binary (exposed vs.
non-exposed), whereas, in this study the risk factors can be in
binary and ordinal scales. For a binary factor, we can use a single
variable to represent it: coded ‘1’ when exposed, ‘0’ otherwise. For
an ordinal factor with a total of L levels (Lw2), we resort to
‘incremental codes’. To be precise, let the ordinal factor be
denoted as X, with X~0 representing its lowest (or unexposed)
level and X~L{1, its highest exposure level, the incremental
codes for X are (a total of L{1 codes for an L-level factor):
I1~1i fX§1, 0 otherwise,
I2~1if X§2, 0 otherwise,
. .
.
IL{1~1if X§L{1, 0 otherwise:
8
> > > > <
> > > > :
With the I1,I2,:::,IL{1 so defined, the regressions are proceeded
using these artificially created incremental codes as the regressors.
(Note that the interaction terms between the incremental codes of
the same risk factor are not allowed.) And then the calculations of
PAFs and CPWs are straightforward as described in Liao and Lee
[23].
All the analyses were performed using SAS version 9.1. The
significance level was set at a~0:05: The additive Poisson
regression was fit using the SAS GENMOD procedure by
specifying the random error as Poisson distribution, and the link
function, the identity link [27]. In addition, we specified the ‘NO
INTERCEPT’ option in the procedure, as an intercept term is not
required in the model [27]. The 95% confidence intervals (95%
CI) for PAF and CPW estimates were derived by the bootstrap
method (10,000 bootstrapping for each estimate) [23].
Interpretation of the Causal-pie Weights
We use two hypothetical binary risk factors, A and B, for
demonstration. There are four possible classes of causal pies (see
figure 1): (I) the disease can occur if risk factor A and other
unknown factors, UI, are present; (II) the disease can occur if risk
factor B and other unknown factors, UII, are present; (III) the
disease can occur if both risk factors A and B, as well as other
unknown factors, UIII, are present; and (IV) the disease can occur
with neither A nor B being present, as long as some unknown
factors, UIV, are present. In this example, class III causal pie is the
most important. It has a CPW of 40%, implying that 40% of the
patients had developed the disease contingent on risk factors A and
B being simultaneously present (or stated differently, these patients
developed the disease through interaction/synergism of the two
risk factors). The CPW of class IV causal pie is 30%. This implies
that 30% of the patients occurred through some certain pathways
that involve none of risk factors A and B. A CPW=20% for class I
implies that 20% of the patients had developed the disease due to
the independent effect of risk factor A. A CPW=10% for class II
implies that only 10% of the patients were the results of the
independent effect of risk factor B.
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Table 1 presents the baseline characteristics of the study
participants (viral factors and habits of cigarette smoking and
alcohol drinking) and the age-adjusted RRs of developing HCC.
(Age-adjusted RRs were obtained from a multiplicative Poisson
regression model including attained age as covariates: ‘30–39’,
‘40–49’, ‘50–59’, ‘60–69’, ‘70+’.) It can be seen that all factors
except for smoking are significantly associated with HCC risk. A
significant dose-response relation can be seen between viral load of
HBV and HCC risk. Compared to individuals with negative
HBsAg status, the RRs are 2.9 (HBV DNA level of ,10
4), 7.0
(HBV DNA between 10
4 and 10
5), 12.7 (HBV DNA between 10
5
and 10
6), and 22.6 (HBV DNA§10
6), respectively. HCV status is
also associated with HCC risk. Those with detectable HCV RNA,
irrespectively of the level being high (RR=6.1) or low (RR=6.1),
have higher risk of HCC than those with undetectable HCV RNA
(RR=1.6) and those with negative anti-HCV (RR=1.0). For
individuals having ever drank, the risk of HCC is 1.4 fold higher
than those never.
Table 2 presents the final additive Poisson regression model
(after adjusting for age). All four incremental codes for the main
effect of HBV status are significant and retained in the final model,
including ‘HBsAg (+)’, ‘HBV DNA§104’, ‘HBV DNA§105’ and
‘HBV DNA§106’. Of the total three incremental codes for the
main effect of HCV RNA, only one is significant: ‘HCV RNA
Detectable’. In addition, the final model contains two interaction
terms, ‘HBsAg (+) 6Alcohol Drinking’ and ‘HBV DNA§105 6
Anti-HCV (+)’.
Table S2 presents the observed and the expected number of
newly-developed HCC patients (and also the crude and the model-
based HCC incidence rates), based on the final model in Table 2.
[Table S2 has a total of 30 ‘cells’: 2 (for alcohol)63 (for HCV)65
(for HBV). This is based on the cut-offs used in the final model in
Table 2.] It can be seen that the observed and the expected are in
good agreement (goodness-of-fit p-values are 0.68 when the data is
grouped into a total of ten cells, and 0.14, when grouped into a
total of four cells).
The PAFs based on the final additive Poisson regression model
are presented in figure 2, from which the magnitudes of case-load
reduction under various public health intervention or treatment
strategies can be inferred. It can be seen that the proportion of
HCC case reduction increases as HBV DNA level is being lowered
down. The increments are rather striking. We observe a chance to
reduce around 60% HCC risk moving from no HBV-related
intervention to the total elimination of virus. An additional ,15%
(or ,5%) reduction can be expected, if the HBV-related
intervention is coupled with an HCV-related intervention (or an
anti-drinking campaign). It makes little difference, though,
whether HCV RNA is totally eliminated or is decreased to
undetectable quantity.
Figure 3 presents the CPWs (and the 95% CIs) of the classes of
causal pies for HCC. (Note that we did not distinguish the different
unknown factors in different classes of causal pies. Rather, we
simply used a capital U to acknowledge them.) There are a total of
eight classes of causal pies (eight ‘pies’ in the figure) playing
important roles in HCC development and each of them with
weights significantly larger than zero. We let the areas of the pies
to be in proportional to their respective CPWs. A CPW for a
particular class of causal pies represents the proportion of HCC
cases attributable to that class. For example, the CPW for the class
of causal pies that contain HBsAg (+) as one of its component
causes is 9.5%. This means that 9.5% of HCC cases had
developed the disease because of their being HBV carriers
regardless of their HBV DNA levels. (Note that an HBV carrier
who had developed HCC may not necessarily have acquired the
disease because of his/her carrier status. He/she may well have
developed the disease through other class of causal pies, if he/she
had completed all the component causes of that class.) As another
example, the CPW for the class of causal pies that includes HBV
DNA§105 and Anti-HCV (+) is 1.7%. This means that 1.7% of
HCC cases occurred because of the synergistic effect of HBV
DNA§105 and Anti-HCV (+).
For clarity, we group the eight classes of causal pies using the
Venn diagram (the three dotted circles in Figure 3, representing the
three sets of ‘HBV’, ‘HCV’ and ‘alcohol drinking’, as well as their
intersections). The HBV ‘circle’ encompasses a total of four dose-
response classes of causal pies representing the independent HBV
effect (CPW~9:5%z15:5%z12:6%z15:1%~52:7%), one class
of HBV-alcohol interaction with small weight (CPW~4:2%), and
one class of HBV-HCV interaction with even smaller weight
(CPW~1:7%). All told, the HBV circle has a total apportioned
weight of 55.7%. (Allthe independent HBV effectcontributes to the
HBV circle, while each of the HBV-alcohol and HBV-HCV
interaction classes contributes only half of its weight to the HBV
circle: 55.7%=52.7%6100%+1.7%650%+4.2%650%.) The
HCV circle encompasses an HCV-only class and an HBV-HCV
interaction class with a total apportioned weight of
14.4%6100%+1.7%650%=15.3%. The alcohol drinking circle
is the smallest. It encompasses only one class of causal pies (the
HBV-alcohol interaction class), which contributes half of its weight
to this circle (apportioned weight~2:1%=4.2%650%). Outside
the circles, the ‘all-U’ class of causal pies (the class of causal pies
Figure 1. Causal pies and causal-pie weights for a hypothetical example. Four possible classes of causal pies for two hypothetical binary risk
factors, A and B, in disease causation. The numbers shown below the pies are the causal-pie weights.
doi:10.1371/journal.pone.0034779.g001
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for the remaining weight of CPW~27:0%.
To gauge the impacts of selection bias, we re-analyzed the data
a number of times, by excluding (1) men residing in a specific
township one at a time; (2) men in a particular age group one at a
time; and (3) men with low-level education, the results were
essentially the same (table S3). We also performed the analysis
excluding patients who were diagnosed as HCC within one year
after enrollment. The results were also essentially the same (table
S3).
Discussion
Due to technological or cost constraint, the detection of HBV
and HCV infection had been largely limited to using serological
tests (for HBsAg and anti-HCV, respectively) in earlier epidemi-
Table 1. Baseline characteristics and the age-adjusted rate ratios for developing hepatocellular carcinoma for a total of 11,801
men who were free of liver cirrhosis and hepatocellular carcinoma at study entry.
Baseline Characteristics Total Person-year Number of Cases
Age-adjusted
Rate Ratio
a p-value
b
HBV status
HBsAg (—) 9458 141984.1 98 1.0
HBV DNAv104c 1250 18789.7 37 2.9 ,0.01
104ƒHBV DNAv105c 398 5887.9 29 7.0 ,0.01
105ƒHBVDNAv106c 281 3961.0 37 12.7 ,0.01
HBV DNA§106c 414 5544.6 97 22.6 ,0.01
HCV status
Anti-HCV (—) 11287 168883.1 242 1.0
HCV RNA undetectable
d 117 1743.6 4 1.6 0.17
HCV RNA detectable: Low
d, e 198 2685.0 26 6.1 ,0.01
HCV RNA detectable: High
d, e 199 2855.5 26 6.1 ,0.01
Cigarette smoking
Never 5141 78375.3 122 1.0
Ever 6660 97791.9 176 1.1 0.18
Alcohol drinking
Never 9371 140886.5 217 1.0
Ever 2430 35280.7 81 1.4 ,0.01
aobtained from a multiplicative Poisson regression model including attained age as covariates: ‘30–39’, ‘40–49’, ‘50–59’, ‘60–69’, ‘70+’.
bone-sided p-value.
calso with HBsAg (+).
dalso with anti-HCV (+); the detection limit is 25 IU/mL.
ethe cut-off point is median RNA loads of study subjects with detectable quantity.
doi:10.1371/journal.pone.0034779.t001
Table 2. The final additive Poisson model based on the data of a total of 11,801 men who were free of liver cirrhosis and
hepatocellular carcinoma at study entry.
Variables
a
Regression Coefficients
(|10{5)
Standard Errors
(|10{5) p-value
b
Intercept 7.7 0.9 ,0.01
HBsAg (+) 83.1 30.0 ,0.01
HBV DNA§104c 299.1 94.2 ,0.01
HBV DNA§105c 394.7 173.3 0.01
HBV DNA§106c 810.3 230.0 ,0.01
HCV RNA Detectable
d 777.0 126.1 ,0.01
HBsAg (+) 6Alcohol Drinking 193.2 92.9 0.02
HBV DNA§105c6Anti-HCV (+) 2273.1 1325.0 0.04
adummy code for alcohol drinking; incremental codes for HBV and HCV status.
bone-sided p-value.
calso with HBsAg (+).
dalso with anti-HCV (+).
doi:10.1371/journal.pone.0034779.t002
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doi:10.1371/journal.pone.0034779.g002
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detect HBV and HCV infection but can also directly measure the
quantities of the viruses in infected persons (the viral loads).
Therefore, we are able to examine the dose-response relation
between viral loads and HCC risk in greater details. For HBV, we
found that the higher its DNA level, the higher the risk of HCC.
As for HCV, the risk for HCC stays pretty much the same as long
as its RNA level is detectable irrespectively of how high it is. Viral
pathogenesis may explain the observed disparity in the dose-
response relations between the two viruses. HBV is a DNA virus
and involves tumorgenesis process by its direct integration into the
host genome [10]. If a person has a high HBV DNA level, the
virus is more likely to be integrated into the host genome. The risk
of HCC would therefore be higher as HBV DNA level increases.
The HCV, being an RNA virus, involves a different mechanism to
cause HCC, however. If the amount of HCV virus was sufficiently
detected by the host immune system, it would take defense to
protect human body. But more or less, liver injury would be
resulted [28,29]. Therefore, the risk of HCC is expected to be
higher once the amount of HCV is accumulated to a certain level.
And over the threshold, since the immune response was induced,
there would be no difference on HCC risk between individuals
who are with lower or higher HCV virus level.
It is of interest to find that the interaction between HBV and
HCV on the risk of HCC is also dose-dependent—the HBV-HCV
interaction occurs only when HBV DNA§105. Previous in vitro
studies showed that co-infection of HBV and HCV leads to a
mutual suppression between the two viruses [30]. We postulate
that the suppression of the HCV on the HBV is less effectual once
the viral load of the latter is becoming too high (HBV DNA§105).
With this threshold crossed, the full potentials of the co-infection of
the two viruses can be unleashed and we then observe a significant
viral interaction on HCC risk.
In this study, we found an interaction effect between alcohol
drinking and positivity of HBsAg on HCC risk, but alcohol
drinking itself lacks an independent effect. Previous studies
conducted in Western countries have shown an increased risk of
HCC for those who consumed alcohol for more than 80 grams per
day (the independent effect of alcohol drinking) [22]. By
comparison, the average dose of alcohol consumption and the
prevalence of alcoholics in Asia are much lower than those in the
Western countries [22,31]. In Taiwan, individuals with problem-
atic alcohol consumption are also proved to be more prevalent in
the aboriginal group than in other ethnic group [32]. This may
explain why this study (mainly focusing on non-aboriginal
Fukienese and Hakka) did not show a significant independent
effect of alcohol drinking. We however caution that even a
relatively mild drinking as in this study suffices to increase the risk
for HCC—not for everyone though, but at least for those HBV
carriers.
Epidemiologists are accustomed to characterize the association
between a risk factor and a disease using an RR index and to
demonstrate a risk factor’s contribution to the disease burden by
using a PAF index. In addition to these commonly used indices, in
this study we further use the CPW index to represent the relative
importance of the various classes of causal pies for HCC. We also
Figure 3. Causal-pie weights and the bootstrapped 95% confidence intervals for newly-developed hepatocellular carcinoma. A total
of eight classes of causal pies (U: unmeasured factors) are presented. The eight pies are grouped into three intersecting sets (the dotted circles).
doi:10.1371/journal.pone.0034779.g003
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classes of causal pies into three circles (HBV, HCV and alcohol
drinking, respectively) and their intersections. From this, an overall
picture of HCC causation then emerges. The big players are HBV
(total apportioned weight: 55.7%) and HCV (15.3%), whereas
alcohol drinking plays a much lesser role (2.1%).
Outside the Venn diagram, there is an all-U class of causal pies
containing none of the measured factors in this study as its
component causes. It accounts for the remaining weight (27.0%).
(This weight estimate is rather stable, judging from its boot-
strapped confidence interval. Moreover, we re-run our analysis
using different a levels. The weight estimates also appear to be
similar: 27.1% when a~0:01, and 26.9% when a~0:1:) An all-U
weight as large as 1=4*1=3 suggests that there are still many risk
factors of HCC awaiting discovery, other than the HBV, HCV
and alcohol drinking that are measured and analyzed in this study.
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